177 related articles for article (PubMed ID: 17172161)
21. Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brain.
Horti AG; Van Laere K
Curr Pharm Des; 2008; 14(31):3363-83. PubMed ID: 19075713
[TBL] [Abstract][Full Text] [Related]
22. Small molecule PET-radiopharmaceuticals.
Elsinga PH; Dierckx RA
Curr Pharm Des; 2014; 20(14):2268-74. PubMed ID: 24025105
[TBL] [Abstract][Full Text] [Related]
23. Small animal PET in preclinical studies: opportunities and challenges.
Riemann B; Schäfers KP; Schober O; Schäfers M
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):215-21. PubMed ID: 18551093
[TBL] [Abstract][Full Text] [Related]
24. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
[TBL] [Abstract][Full Text] [Related]
25. Brain PET and functional MRI: why simultaneously using hybrid PET/MR systems?
Cecchin D; Palombit A; Castellaro M; Silvestri E; Bui F; Barthel H; Sabri O; Corbetta M; Bertoldo A
Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):345-359. PubMed ID: 28750494
[TBL] [Abstract][Full Text] [Related]
26. [Challenges of imaging as a biomarker in drug research and drug].
Miyoshi S
Yakugaku Zasshi; 2014; 134(4):465-72. PubMed ID: 24694805
[TBL] [Abstract][Full Text] [Related]
27. PET and SPECT imaging of the opioid system: receptors, radioligands and avenues for drug discovery and development.
Lever JR
Curr Pharm Des; 2007; 13(1):33-49. PubMed ID: 17266587
[TBL] [Abstract][Full Text] [Related]
28. A positron emission tomography radioligand for the in vivo labeling of metabotropic glutamate 1 receptor: (3-ethyl-2-[11C]methyl-6-quinolinyl)(cis- 4-methoxycyclohexyl)methanone.
Huang Y; Narendran R; Bischoff F; Guo N; Zhu Z; Bae SA; Lesage AS; Laruelle M
J Med Chem; 2005 Aug; 48(16):5096-9. PubMed ID: 16078827
[TBL] [Abstract][Full Text] [Related]
29. Design and Investigation of a [
Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
[TBL] [Abstract][Full Text] [Related]
30. Nitroimidazole-Containing H2dedpa and H2CHXdedpa Derivatives as Potential PET Imaging Agents of Hypoxia with (68)Ga.
Ramogida CF; Pan J; Ferreira CL; Patrick BO; Rebullar K; Yapp DT; Lin KS; Adam MJ; Orvig C
Inorg Chem; 2015 May; 54(10):4953-65. PubMed ID: 25928800
[TBL] [Abstract][Full Text] [Related]
31. Preclinical anaylses of [
Lee B; Kim YK; Lee JY; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
J Cereb Blood Flow Metab; 2017 Jun; 37(6):2283-2293. PubMed ID: 27501957
[TBL] [Abstract][Full Text] [Related]
32. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
33. Gallium-68 in Medical Imaging.
Martiniova L; Palatis L; Etchebehere E; Ravizzini G
Curr Radiopharm; 2016; 9(3):187-207. PubMed ID: 27804868
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat.
Yanamoto K; Yamasaki T; Kumata K; Yui J; Odawara C; Kawamura K; Hatori A; Inoue O; Yamaguchi M; Suzuki K; Zhang MR
Synapse; 2009 Nov; 63(11):961-71. PubMed ID: 19593823
[TBL] [Abstract][Full Text] [Related]
35. Positron emission tomography imaging in evaluation of MS pathology in vivo.
Högel H; Rissanen E; Vuorimaa A; Airas L
Mult Scler; 2018 Oct; 24(11):1399-1412. PubMed ID: 30091657
[TBL] [Abstract][Full Text] [Related]
36. Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.
Rodriguez-Vieitez E; Nordberg A
Methods Mol Biol; 2018; 1750():231-251. PubMed ID: 29512077
[TBL] [Abstract][Full Text] [Related]
37. Production of non-standard PET radionuclides and the application of radiopharmaceuticals labeled with these nuclides.
Welch MJ; Laforest R; Lewis JS
Ernst Schering Res Found Workshop; 2007; (62):159-81. PubMed ID: 17172155
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors.
Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
Mol Pharm; 2016 May; 13(5):1520-7. PubMed ID: 27054811
[TBL] [Abstract][Full Text] [Related]
39. Development of radioligands for imaging of brain norepinephrine transporters in vivo with positron emission tomography.
Schou M; Pike VW; Halldin C
Curr Top Med Chem; 2007; 7(18):1806-16. PubMed ID: 17979789
[TBL] [Abstract][Full Text] [Related]
40. A Promising PET Tracer for Imaging of α₇ Nicotinic Acetylcholine Receptors in the Brain: Design, Synthesis, and in Vivo Evaluation of a Dibenzothiophene-Based Radioligand.
Teodoro R; Scheunemann M; Deuther-Conrad W; Wenzel B; Fasoli FM; Gotti C; Kranz M; Donat CK; Patt M; Hillmer A; Zheng MQ; Peters D; Steinbach J; Sabri O; Huang Y; Brust P
Molecules; 2015 Oct; 20(10):18387-421. PubMed ID: 26473809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
